

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.82803691 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.76086804 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.42645002 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.30661808 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.23787831 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.18033522 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.16010067 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 5.06240042 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 5.02009925 |
| 10 | modulation by symbiont of host defense response (GO:0052031) | 5.02009925 |
| 11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.02009925 |
| 12 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.02009925 |
| 13 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.02009925 |
| 14 | modulation by symbiont of host immune response (GO:0052553) | 5.02009925 |
| 15 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.99503423 |
| 16 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.89144382 |
| 17 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.66635648 |
| 18 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.64717568 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.63720834 |
| 20 | negative regulation of cell killing (GO:0031342) | 4.63720834 |
| 21 | glutamate secretion (GO:0014047) | 4.62340979 |
| 22 | detection of other organism (GO:0098543) | 4.55209780 |
| 23 | detection of bacterium (GO:0016045) | 4.53913007 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 4.52217619 |
| 25 | response to peptidoglycan (GO:0032494) | 4.50803286 |
| 26 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.46553213 |
| 27 | vocalization behavior (GO:0071625) | 4.42782695 |
| 28 | leukocyte aggregation (GO:0070486) | 4.38913251 |
| 29 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.32480645 |
| 30 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.24040684 |
| 31 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.21851545 |
| 32 | regulation of gamma-delta T cell activation (GO:0046643) | 4.18966436 |
| 33 | macrophage activation involved in immune response (GO:0002281) | 4.18555463 |
| 34 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.14916130 |
| 35 | exploration behavior (GO:0035640) | 4.12004134 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 4.09261099 |
| 37 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.97773233 |
| 38 | immunoglobulin mediated immune response (GO:0016064) | 3.94898051 |
| 39 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.94008293 |
| 40 | protein localization to synapse (GO:0035418) | 3.92198309 |
| 41 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.87057049 |
| 42 | neurotransmitter secretion (GO:0007269) | 3.85972091 |
| 43 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.83812777 |
| 44 | regulation of synaptic vesicle transport (GO:1902803) | 3.83762551 |
| 45 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.83706051 |
| 46 | sodium ion export (GO:0071436) | 3.75739183 |
| 47 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.74704895 |
| 48 | neuronal action potential propagation (GO:0019227) | 3.74421621 |
| 49 | cellular extravasation (GO:0045123) | 3.73739170 |
| 50 | regulation of synapse structural plasticity (GO:0051823) | 3.72790107 |
| 51 | response to muramyl dipeptide (GO:0032495) | 3.67990830 |
| 52 | layer formation in cerebral cortex (GO:0021819) | 3.67913716 |
| 53 | positive thymic T cell selection (GO:0045059) | 3.64229540 |
| 54 | detection of external biotic stimulus (GO:0098581) | 3.64163670 |
| 55 | respiratory burst (GO:0045730) | 3.58038305 |
| 56 | regulation of mast cell degranulation (GO:0043304) | 3.54551982 |
| 57 | positive regulation of synapse maturation (GO:0090129) | 3.52442761 |
| 58 | B cell receptor signaling pathway (GO:0050853) | 3.52123976 |
| 59 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.50025392 |
| 60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.47551828 |
| 61 | glutamate receptor signaling pathway (GO:0007215) | 3.47468530 |
| 62 | positive regulation of B cell differentiation (GO:0045579) | 3.46206788 |
| 63 | long-term memory (GO:0007616) | 3.43652773 |
| 64 | negative regulation of T cell mediated immunity (GO:0002710) | 3.41027346 |
| 65 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.39067583 |
| 66 | regulation of leukocyte degranulation (GO:0043300) | 3.38856691 |
| 67 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.36070637 |
| 68 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.34889001 |
| 69 | NIK/NF-kappaB signaling (GO:0038061) | 3.33753756 |
| 70 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.33245058 |
| 71 | cellular potassium ion homeostasis (GO:0030007) | 3.30985313 |
| 72 | thymic T cell selection (GO:0045061) | 3.30939710 |
| 73 | regulation of B cell differentiation (GO:0045577) | 3.29505965 |
| 74 | regulation of T cell tolerance induction (GO:0002664) | 3.27734974 |
| 75 | synaptic vesicle endocytosis (GO:0048488) | 3.27163028 |
| 76 | synaptic transmission, glutamatergic (GO:0035249) | 3.26666683 |
| 77 | T cell selection (GO:0045058) | 3.26586469 |
| 78 | dendritic spine morphogenesis (GO:0060997) | 3.24612963 |
| 79 | response to interleukin-15 (GO:0070672) | 3.23873004 |
| 80 | detection of biotic stimulus (GO:0009595) | 3.23817826 |
| 81 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.23120186 |
| 82 | response to host immune response (GO:0052572) | 3.23120186 |
| 83 | neutrophil activation (GO:0042119) | 3.21929559 |
| 84 | negative regulation of phagocytosis (GO:0050765) | 3.21656871 |
| 85 | positive regulation of membrane potential (GO:0045838) | 3.20502320 |
| 86 | regulation of ARF protein signal transduction (GO:0032012) | 3.19852783 |
| 87 | myeloid cell activation involved in immune response (GO:0002275) | 3.19398151 |
| 88 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.17587606 |
| 89 | activation of protein kinase A activity (GO:0034199) | 3.15592385 |
| 90 | germinal center formation (GO:0002467) | 3.15102416 |
| 91 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.14880708 |
| 92 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.14848143 |
| 93 | cellular response to type I interferon (GO:0071357) | 3.14347208 |
| 94 | type I interferon signaling pathway (GO:0060337) | 3.14347208 |
| 95 | neuron cell-cell adhesion (GO:0007158) | 3.13843993 |
| 96 | proline transport (GO:0015824) | 3.13070897 |
| 97 | response to type I interferon (GO:0034340) | 3.12953013 |
| 98 | neuron-neuron synaptic transmission (GO:0007270) | 3.12579454 |
| 99 | T cell migration (GO:0072678) | 3.10641683 |
| 100 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.09577740 |
| 101 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09240110 |
| 102 | tolerance induction (GO:0002507) | 3.08682662 |
| 103 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.08262784 |
| 104 | response to host (GO:0075136) | 3.08262784 |
| 105 | response to host defenses (GO:0052200) | 3.08262784 |
| 106 | granulocyte activation (GO:0036230) | 3.07359183 |
| 107 | B cell mediated immunity (GO:0019724) | 3.05831535 |
| 108 | regulation of tolerance induction (GO:0002643) | 3.05360321 |
| 109 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.04902384 |
| 110 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.04813213 |
| 111 | regulation of synaptic plasticity (GO:0048167) | 3.04662706 |
| 112 | detection of molecule of bacterial origin (GO:0032490) | 3.02361997 |
| 113 | negative regulation of microtubule polymerization (GO:0031115) | 3.00262489 |
| 114 | mannose metabolic process (GO:0006013) | 3.00182777 |
| 115 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.98381262 |
| 116 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.97946783 |
| 117 | neuromuscular process controlling posture (GO:0050884) | 2.96303585 |
| 118 | response to histamine (GO:0034776) | 2.96138463 |
| 119 | neuromuscular process controlling balance (GO:0050885) | 2.95648157 |
| 120 | positive regulation of mast cell activation (GO:0033005) | 2.94260242 |
| 121 | defense response to protozoan (GO:0042832) | 2.93875541 |
| 122 | neurotransmitter transport (GO:0006836) | 2.93380520 |
| 123 | positive T cell selection (GO:0043368) | 2.93015599 |
| 124 | regulation of antigen processing and presentation (GO:0002577) | 2.92553539 |
| 125 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.92328996 |
| 126 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.90415306 |
| 127 | regulation of postsynaptic membrane potential (GO:0060078) | 2.88080897 |
| 128 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.88072047 |
| 129 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.87425345 |
| 130 | regulation of ARF GTPase activity (GO:0032312) | 2.86213632 |
| 131 | positive regulation of neurotransmitter transport (GO:0051590) | 2.85207890 |
| 132 | positive regulation of antigen processing and presentation (GO:0002579) | 2.84711344 |
| 133 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.84390675 |
| 134 | dopamine receptor signaling pathway (GO:0007212) | 2.83861407 |
| 135 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.82960464 |
| 136 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.82759606 |
| 137 | gamma-aminobutyric acid transport (GO:0015812) | 2.80210813 |
| 138 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.80004735 |
| 139 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.80004735 |
| 140 | prepulse inhibition (GO:0060134) | 2.79297824 |
| 141 | negative regulation of innate immune response (GO:0045824) | 2.79195448 |
| 142 | cellular response to interleukin-15 (GO:0071350) | 2.78416366 |
| 143 | regulation of regulated secretory pathway (GO:1903305) | 2.78294987 |
| 144 | regulation of neurotransmitter levels (GO:0001505) | 2.78099612 |
| 145 | long-term synaptic potentiation (GO:0060291) | 2.77846224 |
| 146 | regulation of vesicle fusion (GO:0031338) | 2.77525666 |
| 147 | macrophage activation (GO:0042116) | 2.76852725 |
| 148 | regulation of mast cell activation (GO:0033003) | 2.76794847 |
| 149 | response to protozoan (GO:0001562) | 2.76497000 |
| 150 | myeloid dendritic cell differentiation (GO:0043011) | 2.75516660 |
| 151 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.74812984 |
| 152 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.74459202 |
| 153 | myeloid dendritic cell activation (GO:0001773) | 2.74067321 |
| 154 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.72818906 |
| 155 | regulation of neurotransmitter secretion (GO:0046928) | 2.71891246 |
| 156 | signal complex assembly (GO:0007172) | 2.71754259 |
| 157 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.71206252 |
| 158 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.70231700 |
| 159 | positive regulation of fibroblast migration (GO:0010763) | 2.68726618 |
| 160 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.68420095 |
| 161 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.68369586 |
| 162 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.67211031 |
| 163 | microglial cell activation (GO:0001774) | 2.66489446 |
| 164 | leukocyte degranulation (GO:0043299) | 2.66251264 |
| 165 | positive regulation of dendritic spine development (GO:0060999) | 2.66251003 |
| 166 | clathrin coat assembly (GO:0048268) | 2.64224299 |
| 167 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.63384022 |
| 168 | negative regulation of interleukin-6 production (GO:0032715) | 2.63329742 |
| 169 | behavioral fear response (GO:0001662) | 2.61956287 |
| 170 | behavioral defense response (GO:0002209) | 2.61956287 |
| 171 | vesicle transport along microtubule (GO:0047496) | 2.59062735 |
| 172 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.57470903 |
| 173 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.56359043 |
| 174 | response to pheromone (GO:0019236) | 2.55025308 |
| 175 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.51536499 |
| 176 | regulation of neurotransmitter transport (GO:0051588) | 2.51429229 |
| 177 | social behavior (GO:0035176) | 2.50518464 |
| 178 | intraspecies interaction between organisms (GO:0051703) | 2.50518464 |
| 179 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.49848662 |
| 180 | negative thymic T cell selection (GO:0045060) | 2.48862492 |
| 181 | establishment of synaptic vesicle localization (GO:0097480) | 2.47972251 |
| 182 | synaptic vesicle transport (GO:0048489) | 2.47972251 |
| 183 | auditory behavior (GO:0031223) | 2.46328466 |
| 184 | response to auditory stimulus (GO:0010996) | 2.46285077 |
| 185 | learning (GO:0007612) | 2.45957582 |
| 186 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.45829488 |
| 187 | positive regulation of synaptic transmission (GO:0050806) | 2.45590166 |
| 188 | membrane depolarization (GO:0051899) | 2.45466194 |
| 189 | negative T cell selection (GO:0043383) | 2.42263572 |
| 190 | regulation of synaptic transmission (GO:0050804) | 2.42131001 |
| 191 | fear response (GO:0042596) | 2.40355630 |
| 192 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.39885481 |
| 193 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.39063021 |
| 194 | transmission of nerve impulse (GO:0019226) | 2.37368718 |
| 195 | regulation of defense response to virus by virus (GO:0050690) | 2.36167545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.96083929 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.26783730 |
| 3 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 3.27782291 |
| 4 | * IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.23196682 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.22135805 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.15579036 |
| 7 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 3.06424043 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.92575101 |
| 9 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.79130036 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.64955262 |
| 11 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.52333624 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.47183789 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.42401089 |
| 14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.40539177 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.35148348 |
| 16 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.34471338 |
| 17 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.31835993 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.24546603 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.24469818 |
| 20 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.24157979 |
| 21 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.23337228 |
| 22 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.21773134 |
| 23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.20875419 |
| 24 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.19588791 |
| 25 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.17549966 |
| 26 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.17009287 |
| 27 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 2.16878155 |
| 28 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.13935786 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.12589269 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.11691343 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.05807190 |
| 32 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.02831850 |
| 33 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.00994426 |
| 34 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.92309476 |
| 35 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.89399253 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.86924056 |
| 37 | KDM2B_26808549_Chip-Seq_K562_Human | 1.85986132 |
| 38 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.85526323 |
| 39 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.85012111 |
| 40 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.83913543 |
| 41 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.83114814 |
| 42 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.82278718 |
| 43 | MYB_26560356_Chip-Seq_TH1_Human | 1.78668138 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73907509 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73762119 |
| 46 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.72988015 |
| 47 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.72949983 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.72275317 |
| 49 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.71839155 |
| 50 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.71727908 |
| 51 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.70503470 |
| 52 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.68878432 |
| 53 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.68527526 |
| 54 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.68527526 |
| 55 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.63212640 |
| 56 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.61495945 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60461683 |
| 58 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.55344291 |
| 59 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.54015365 |
| 60 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.52632422 |
| 61 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.51667388 |
| 62 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.51613973 |
| 63 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.51034618 |
| 64 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.50777087 |
| 65 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.50524573 |
| 66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.49612849 |
| 67 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48608341 |
| 68 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.48545908 |
| 69 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48387058 |
| 70 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.47018933 |
| 71 | MAF_26560356_Chip-Seq_TH1_Human | 1.46785210 |
| 72 | UTX_26944678_Chip-Seq_JUKART_Human | 1.44935836 |
| 73 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.44829132 |
| 74 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.44236687 |
| 75 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43138111 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.43003098 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.42660852 |
| 78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40108717 |
| 79 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39546309 |
| 80 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.35943228 |
| 81 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.35660607 |
| 82 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.35555669 |
| 83 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35141661 |
| 84 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.33797180 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33791498 |
| 86 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33488594 |
| 87 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.32594017 |
| 88 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.32472272 |
| 89 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.32051151 |
| 90 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31143772 |
| 91 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.30765887 |
| 92 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.30553773 |
| 93 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.29301115 |
| 94 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27784807 |
| 95 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.26066296 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.25354431 |
| 97 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.23700481 |
| 98 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23412431 |
| 99 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22342396 |
| 100 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.22231044 |
| 101 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21096248 |
| 102 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.20948451 |
| 103 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20926362 |
| 104 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.19968386 |
| 105 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.19113722 |
| 106 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.16983589 |
| 107 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.14365785 |
| 108 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14122240 |
| 109 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.13603657 |
| 110 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13246877 |
| 111 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12075093 |
| 112 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11941597 |
| 113 | MAF_26560356_Chip-Seq_TH2_Human | 1.11430902 |
| 114 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10587200 |
| 115 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09977510 |
| 116 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09660419 |
| 117 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09568444 |
| 118 | * P68_20966046_ChIP-Seq_HELA_Human | 1.09473835 |
| 119 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09036150 |
| 120 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08062211 |
| 121 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07990414 |
| 122 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07626410 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06403252 |
| 124 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.05922308 |
| 125 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05288106 |
| 126 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05070759 |
| 127 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04990017 |
| 128 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04879387 |
| 129 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04763268 |
| 130 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.03710671 |
| 131 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03602186 |
| 132 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.03518992 |
| 133 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.98989566 |
| 134 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97785792 |
| 135 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97264147 |
| 136 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96980395 |
| 137 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95662039 |
| 138 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.95440342 |
| 139 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.94703411 |
| 140 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.93842017 |
| 141 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.93778669 |
| 142 | MYB_26560356_Chip-Seq_TH2_Human | 0.93759167 |
| 143 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93399076 |
| 144 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.91259156 |
| 145 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90374377 |
| 146 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.90135290 |
| 147 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.89999634 |
| 148 | * SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.88656483 |
| 149 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.88466040 |
| 150 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.88056419 |
| 151 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.87610560 |
| 152 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.87071146 |
| 153 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.87047282 |
| 154 | SA1_27219007_Chip-Seq_Bcells_Human | 0.85825383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.38872907 |
| 2 | MP0003436_decreased_susceptibility_to | 4.06324442 |
| 3 | MP0003880_abnormal_central_pattern | 4.01401632 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.88786250 |
| 5 | MP0003724_increased_susceptibility_to | 3.13364696 |
| 6 | MP0009745_abnormal_behavioral_response | 3.00859508 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.00644204 |
| 8 | MP0002419_abnormal_innate_immunity | 2.88052501 |
| 9 | MP0002064_seizures | 2.86609252 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.82410978 |
| 11 | MP0005025_abnormal_response_to | 2.75136369 |
| 12 | MP0009046_muscle_twitch | 2.71749661 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.60552494 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.57198929 |
| 15 | MP0009785_altered_susceptibility_to | 2.54415368 |
| 16 | MP0002572_abnormal_emotion/affect_behav | 2.47520534 |
| 17 | MP0006082_CNS_inflammation | 2.45500130 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.26312664 |
| 19 | MP0002822_catalepsy | 2.26126570 |
| 20 | MP0004270_analgesia | 2.22413071 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.21016491 |
| 22 | MP0004947_skin_inflammation | 2.10115468 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.09278219 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 2.05496980 |
| 25 | MP0008569_lethality_at_weaning | 1.99154686 |
| 26 | MP0002272_abnormal_nervous_system | 1.98162195 |
| 27 | MP0008260_abnormal_autophagy | 1.95454943 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.93694841 |
| 29 | MP0002736_abnormal_nociception_after | 1.92191699 |
| 30 | MP0001533_abnormal_skeleton_physiology | 1.91746220 |
| 31 | MP0005451_abnormal_body_composition | 1.90603974 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.89202902 |
| 33 | MP0003787_abnormal_imprinting | 1.82331343 |
| 34 | MP0003303_peritoneal_inflammation | 1.80148224 |
| 35 | MP0004510_myositis | 1.79033173 |
| 36 | MP0003122_maternal_imprinting | 1.77095453 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.76614010 |
| 38 | MP0001486_abnormal_startle_reflex | 1.76595780 |
| 39 | MP0000858_altered_metastatic_potential | 1.72813804 |
| 40 | MP0001845_abnormal_inflammatory_respons | 1.71953992 |
| 41 | MP0001970_abnormal_pain_threshold | 1.69261382 |
| 42 | MP0002733_abnormal_thermal_nociception | 1.69061473 |
| 43 | MP0002734_abnormal_mechanical_nocicepti | 1.62683046 |
| 44 | MP0004858_abnormal_nervous_system | 1.60211326 |
| 45 | MP0001440_abnormal_grooming_behavior | 1.53544694 |
| 46 | MP0001873_stomach_inflammation | 1.51331930 |
| 47 | MP0003828_pulmonary_edema | 1.50332139 |
| 48 | MP0002184_abnormal_innervation | 1.49773183 |
| 49 | MP0008961_abnormal_basal_metabolism | 1.49159431 |
| 50 | MP0003123_paternal_imprinting | 1.48248922 |
| 51 | MP0002067_abnormal_sensory_capabilities | 1.46853881 |
| 52 | MP0009840_abnormal_foam_cell | 1.46602496 |
| 53 | MP0003172_abnormal_lysosome_physiology | 1.45931281 |
| 54 | MP0002557_abnormal_social/conspecific_i | 1.45294985 |
| 55 | MP0002909_abnormal_adrenal_gland | 1.44352362 |
| 56 | MP0003329_amyloid_beta_deposits | 1.44119090 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.43694643 |
| 58 | MP0002998_abnormal_bone_remodeling | 1.41603054 |
| 59 | MP0008469_abnormal_protein_level | 1.39567642 |
| 60 | MP0002735_abnormal_chemical_nociception | 1.39090433 |
| 61 | MP0004381_abnormal_hair_follicle | 1.37295554 |
| 62 | MP0002132_abnormal_respiratory_system | 1.34451227 |
| 63 | MP0000490_abnormal_crypts_of | 1.32977816 |
| 64 | MP0004924_abnormal_behavior | 1.29094345 |
| 65 | MP0005386_behavior/neurological_phenoty | 1.29094345 |
| 66 | MP0001851_eye_inflammation | 1.24568293 |
| 67 | MP0003763_abnormal_thymus_physiology | 1.23345956 |
| 68 | MP0000955_abnormal_spinal_cord | 1.21961173 |
| 69 | MP0008872_abnormal_physiological_respon | 1.21301432 |
| 70 | MP0000569_abnormal_digit_pigmentation | 1.21149821 |
| 71 | MP0003705_abnormal_hypodermis_morpholog | 1.20766982 |
| 72 | MP0001529_abnormal_vocalization | 1.19853179 |
| 73 | MP0003879_abnormal_hair_cell | 1.18843033 |
| 74 | MP0002396_abnormal_hematopoietic_system | 1.17496626 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 1.17448708 |
| 76 | MP0001853_heart_inflammation | 1.17367496 |
| 77 | MP0004142_abnormal_muscle_tone | 1.13578564 |
| 78 | MP0005499_abnormal_olfactory_system | 1.13181770 |
| 79 | MP0005394_taste/olfaction_phenotype | 1.13181770 |
| 80 | MP0003075_altered_response_to | 1.12360115 |
| 81 | MP0002066_abnormal_motor_capabilities/c | 1.10690042 |
| 82 | MP0003121_genomic_imprinting | 1.10237059 |
| 83 | MP0002398_abnormal_bone_marrow | 1.10058058 |
| 84 | MP0000685_abnormal_immune_system | 1.09622978 |
| 85 | MP0002166_altered_tumor_susceptibility | 1.08123453 |
| 86 | MP0005671_abnormal_response_to | 1.07749406 |
| 87 | MP0005166_decreased_susceptibility_to | 1.06727405 |
| 88 | MP0002882_abnormal_neuron_morphology | 1.06207316 |
| 89 | MP0005310_abnormal_salivary_gland | 1.04172526 |
| 90 | MP0008874_decreased_physiological_sensi | 1.03442519 |
| 91 | MP0001905_abnormal_dopamine_level | 1.02973949 |
| 92 | MP0001849_ear_inflammation | 1.00992601 |
| 93 | MP0003448_altered_tumor_morphology | 1.00957285 |
| 94 | MP0009764_decreased_sensitivity_to | 1.00836960 |
| 95 | MP0000778_abnormal_nervous_system | 1.00434687 |
| 96 | MP0000703_abnormal_thymus_morphology | 0.97121946 |
| 97 | MP0000343_altered_response_to | 0.96615381 |
| 98 | MP0002152_abnormal_brain_morphology | 0.95567685 |
| 99 | MP0003633_abnormal_nervous_system | 0.94799331 |
| 100 | MP0001348_abnormal_lacrimal_gland | 0.94155783 |
| 101 | MP0005645_abnormal_hypothalamus_physiol | 0.93701837 |
| 102 | MP0001502_abnormal_circadian_rhythm | 0.93422338 |
| 103 | MP0005174_abnormal_tail_pigmentation | 0.93306041 |
| 104 | MP0002420_abnormal_adaptive_immunity | 0.90601305 |
| 105 | MP0001663_abnormal_digestive_system | 0.90213755 |
| 106 | MP0006276_abnormal_autonomic_nervous | 0.90194088 |
| 107 | MP0001819_abnormal_immune_cell | 0.89855954 |
| 108 | MP0001545_abnormal_hematopoietic_system | 0.89715942 |
| 109 | MP0005397_hematopoietic_system_phenotyp | 0.89715942 |
| 110 | MP0001984_abnormal_olfaction | 0.89340314 |
| 111 | MP0003091_abnormal_cell_migration | 0.88855310 |
| 112 | MP0004883_abnormal_blood_vessel | 0.88020374 |
| 113 | MP0004808_abnormal_hematopoietic_stem | 0.87278130 |
| 114 | MP0003866_abnormal_defecation | 0.85608762 |
| 115 | MP0002933_joint_inflammation | 0.84740615 |
| 116 | MP0008004_abnormal_stomach_pH | 0.84012527 |
| 117 | MP0003806_abnormal_nucleotide_metabolis | 0.83686174 |
| 118 | MP0001800_abnormal_humoral_immune | 0.83601134 |
| 119 | MP0004264_abnormal_extraembryonic_tissu | 0.83548671 |
| 120 | MP0001835_abnormal_antigen_presentation | 0.83038033 |
| 121 | MP0005390_skeleton_phenotype | 0.82411594 |
| 122 | MP0002722_abnormal_immune_system | 0.82009339 |
| 123 | MP0003690_abnormal_glial_cell | 0.81797211 |
| 124 | MP0008770_decreased_survivor_rate | 0.81342196 |
| 125 | MP0000716_abnormal_immune_system | 0.80886422 |
| 126 | MP0003566_abnormal_cell_adhesion | 0.78365201 |
| 127 | MP0002723_abnormal_immune_serum | 0.78058502 |
| 128 | MP0010234_abnormal_vibrissa_follicle | 0.78040447 |
| 129 | MP0002796_impaired_skin_barrier | 0.77842480 |
| 130 | MP0005000_abnormal_immune_tolerance | 0.77255951 |
| 131 | MP0009763_increased_sensitivity_to | 0.76061063 |
| 132 | MP0008877_abnormal_DNA_methylation | 0.74197874 |
| 133 | MP0002277_abnormal_respiratory_mucosa | 0.73998605 |
| 134 | MP0003183_abnormal_peptide_metabolism | 0.73716831 |
| 135 | MP0003795_abnormal_bone_structure | 0.72847983 |
| 136 | MP0004185_abnormal_adipocyte_glucose | 0.72646451 |
| 137 | MP0000689_abnormal_spleen_morphology | 0.72461014 |
| 138 | MP0003631_nervous_system_phenotype | 0.72290608 |
| 139 | MP0000604_amyloidosis | 0.71676185 |
| 140 | MP0002138_abnormal_hepatobiliary_system | 0.71343192 |
| 141 | MP0002452_abnormal_antigen_presenting | 0.71070515 |
| 142 | MP0005464_abnormal_platelet_physiology | 0.70270893 |
| 143 | MP0005646_abnormal_pituitary_gland | 0.69260019 |
| 144 | MP0002254_reproductive_system_inflammat | 0.68586359 |
| 145 | MP0002006_tumorigenesis | 0.68115666 |
| 146 | MP0004885_abnormal_endolymph | 0.67358083 |
| 147 | MP0005164_abnormal_response_to | 0.67137642 |
| 148 | MP0002429_abnormal_blood_cell | 0.66374353 |
| 149 | MP0002069_abnormal_eating/drinking_beha | 0.65239161 |
| 150 | MP0005387_immune_system_phenotype | 0.62538571 |
| 151 | MP0001790_abnormal_immune_system | 0.62538571 |
| 152 | MP0002653_abnormal_ependyma_morphology | 0.61690360 |
| 153 | MP0002019_abnormal_tumor_incidence | 0.61171947 |
| 154 | MP0000249_abnormal_blood_vessel | 0.61058273 |
| 155 | MP0005076_abnormal_cell_differentiation | 0.60668417 |
| 156 | MP0005075_abnormal_melanosome_morpholog | 0.59980346 |
| 157 | MP0009278_abnormal_bone_marrow | 0.59365677 |
| 158 | MP0005381_digestive/alimentary_phenotyp | 0.58134785 |
| 159 | MP0000015_abnormal_ear_pigmentation | 0.57853358 |
| 160 | MP0009765_abnormal_xenobiotic_induced | 0.57769356 |
| 161 | MP0002877_abnormal_melanocyte_morpholog | 0.57634335 |
| 162 | MP0005023_abnormal_wound_healing | 0.57489981 |
| 163 | MP0002083_premature_death | 0.56850604 |
| 164 | MP0002405_respiratory_system_inflammati | 0.55982006 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.15357879 |
| 2 | Focal motor seizures (HP:0011153) | 5.74118150 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.36185093 |
| 4 | Recurrent abscess formation (HP:0002722) | 5.32968164 |
| 5 | Visual hallucinations (HP:0002367) | 5.25661723 |
| 6 | Abnormality of macrophages (HP:0004311) | 5.09534265 |
| 7 | Myokymia (HP:0002411) | 5.07348772 |
| 8 | Focal seizures (HP:0007359) | 4.51582439 |
| 9 | Myositis (HP:0100614) | 4.28746631 |
| 10 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.95460112 |
| 11 | Orchitis (HP:0100796) | 3.82768552 |
| 12 | Obstructive lung disease (HP:0006536) | 3.78303751 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.78303751 |
| 14 | Meningitis (HP:0001287) | 3.71072083 |
| 15 | Epileptic encephalopathy (HP:0200134) | 3.64883971 |
| 16 | Atonic seizures (HP:0010819) | 3.57612916 |
| 17 | Recurrent skin infections (HP:0001581) | 3.56928163 |
| 18 | Annular pancreas (HP:0001734) | 3.51272312 |
| 19 | Papilledema (HP:0001085) | 3.47345044 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.47082378 |
| 21 | Optic neuritis (HP:0100653) | 3.47082378 |
| 22 | Progressive cerebellar ataxia (HP:0002073) | 3.46464459 |
| 23 | Febrile seizures (HP:0002373) | 3.40912690 |
| 24 | Stomatitis (HP:0010280) | 3.39156021 |
| 25 | Spontaneous hematomas (HP:0007420) | 3.37130061 |
| 26 | Cellulitis (HP:0100658) | 3.34124285 |
| 27 | Gastrointestinal infarctions (HP:0005244) | 3.24103761 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.23415779 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 3.23415779 |
| 30 | Recurrent viral infections (HP:0004429) | 3.18349356 |
| 31 | Pustule (HP:0200039) | 3.18055126 |
| 32 | Gingivitis (HP:0000230) | 3.18052704 |
| 33 | Gastrointestinal inflammation (HP:0004386) | 3.14988536 |
| 34 | Absence seizures (HP:0002121) | 3.13127386 |
| 35 | Inflammation of the large intestine (HP:0002037) | 3.10607519 |
| 36 | Vasculitis (HP:0002633) | 3.10087082 |
| 37 | Supranuclear gaze palsy (HP:0000605) | 3.08213619 |
| 38 | Urticaria (HP:0001025) | 3.06552348 |
| 39 | Colitis (HP:0002583) | 3.03654917 |
| 40 | Depression (HP:0000716) | 3.02370127 |
| 41 | Mutism (HP:0002300) | 3.00615216 |
| 42 | Encephalitis (HP:0002383) | 3.00154028 |
| 43 | Dialeptic seizures (HP:0011146) | 2.92944831 |
| 44 | Abnormality of the lower motor neuron (HP:0002366) | 2.90545186 |
| 45 | Amyotrophic lateral sclerosis (HP:0007354) | 2.86597032 |
| 46 | Pointed chin (HP:0000307) | 2.83798515 |
| 47 | Diplopia (HP:0000651) | 2.82915822 |
| 48 | Abnormality of binocular vision (HP:0011514) | 2.82915822 |
| 49 | Impaired smooth pursuit (HP:0007772) | 2.80676110 |
| 50 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.78789994 |
| 51 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.78789994 |
| 52 | Abnormality of glycolipid metabolism (HP:0010969) | 2.78789994 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.78304214 |
| 54 | Generalized tonic-clonic seizures (HP:0002069) | 2.69474141 |
| 55 | Hyperacusis (HP:0010780) | 2.67919014 |
| 56 | Agammaglobulinemia (HP:0004432) | 2.64219005 |
| 57 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.62846315 |
| 58 | Hemiplegia (HP:0002301) | 2.62519209 |
| 59 | Poor eye contact (HP:0000817) | 2.62053537 |
| 60 | Petechiae (HP:0000967) | 2.60202683 |
| 61 | Chest pain (HP:0100749) | 2.59294108 |
| 62 | Gastrointestinal stroma tumor (HP:0100723) | 2.58219299 |
| 63 | T lymphocytopenia (HP:0005403) | 2.57725410 |
| 64 | Insomnia (HP:0100785) | 2.57664502 |
| 65 | Keratoconjunctivitis sicca (HP:0001097) | 2.56921935 |
| 66 | Truncal ataxia (HP:0002078) | 2.55119662 |
| 67 | Lymphopenia (HP:0001888) | 2.50802642 |
| 68 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.50392803 |
| 69 | Pulmonary infiltrates (HP:0002113) | 2.49619706 |
| 70 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.47092743 |
| 71 | Osteomyelitis (HP:0002754) | 2.46710954 |
| 72 | Epistaxis (HP:0000421) | 2.45947895 |
| 73 | Hemoptysis (HP:0002105) | 2.45940445 |
| 74 | Ankle clonus (HP:0011448) | 2.45727213 |
| 75 | Impaired social interactions (HP:0000735) | 2.44812576 |
| 76 | Abnormal social behavior (HP:0012433) | 2.44812576 |
| 77 | Apathy (HP:0000741) | 2.43954288 |
| 78 | Amblyopia (HP:0000646) | 2.41132364 |
| 79 | Stereotypic behavior (HP:0000733) | 2.40560186 |
| 80 | Loss of speech (HP:0002371) | 2.39178047 |
| 81 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.38468612 |
| 82 | Diminished motivation (HP:0000745) | 2.37697077 |
| 83 | Dysostosis multiplex (HP:0000943) | 2.37176209 |
| 84 | Abnormality of T cell number (HP:0011839) | 2.35933302 |
| 85 | Abnormal eating behavior (HP:0100738) | 2.35653479 |
| 86 | Systemic lupus erythematosus (HP:0002725) | 2.35299264 |
| 87 | Abnormality of T cells (HP:0002843) | 2.34804220 |
| 88 | Purpura (HP:0000979) | 2.34729222 |
| 89 | Premature loss of primary teeth (HP:0006323) | 2.33643571 |
| 90 | Postural instability (HP:0002172) | 2.30250971 |
| 91 | Malnutrition (HP:0004395) | 2.29173731 |
| 92 | Broad-based gait (HP:0002136) | 2.27855338 |
| 93 | Keratoconjunctivitis (HP:0001096) | 2.27827017 |
| 94 | Failure to thrive in infancy (HP:0001531) | 2.26778389 |
| 95 | Large eyes (HP:0001090) | 2.26328480 |
| 96 | Hemiparesis (HP:0001269) | 2.25989982 |
| 97 | Action tremor (HP:0002345) | 2.25883769 |
| 98 | Granulocytopenia (HP:0001913) | 2.24703201 |
| 99 | Genetic anticipation (HP:0003743) | 2.24487845 |
| 100 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.23970045 |
| 101 | Increased IgM level (HP:0003496) | 2.23759364 |
| 102 | Dysmetric saccades (HP:0000641) | 2.20523504 |
| 103 | Gaze-evoked nystagmus (HP:0000640) | 2.19736782 |
| 104 | Gingival bleeding (HP:0000225) | 2.18405520 |
| 105 | Dysdiadochokinesis (HP:0002075) | 2.18095186 |
| 106 | Amyloidosis (HP:0011034) | 2.18066704 |
| 107 | Leukocytosis (HP:0001974) | 2.17421183 |
| 108 | Increased serum ferritin (HP:0003281) | 2.17045295 |
| 109 | Skin ulcer (HP:0200042) | 2.16296113 |
| 110 | Sepsis (HP:0100806) | 2.15547467 |
| 111 | Hypochromic anemia (HP:0001931) | 2.14676025 |
| 112 | Bradykinesia (HP:0002067) | 2.14151565 |
| 113 | IgM deficiency (HP:0002850) | 2.13592500 |
| 114 | Vacuolated lymphocytes (HP:0001922) | 2.13512228 |
| 115 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.13492980 |
| 116 | Arterial thrombosis (HP:0004420) | 2.13047003 |
| 117 | Slow saccadic eye movements (HP:0000514) | 2.11548148 |
| 118 | Dysmetria (HP:0001310) | 2.10023109 |
| 119 | Verrucae (HP:0200043) | 2.09482349 |
| 120 | Papilloma (HP:0012740) | 2.09482349 |
| 121 | Urinary urgency (HP:0000012) | 2.09323861 |
| 122 | Pulmonary embolism (HP:0002204) | 2.07602955 |
| 123 | Progressive inability to walk (HP:0002505) | 2.07293430 |
| 124 | Hypergammaglobulinemia (HP:0010702) | 2.07203485 |
| 125 | Polygenic inheritance (HP:0010982) | 2.06495741 |
| 126 | Restrictive lung disease (HP:0002091) | 2.05255195 |
| 127 | Abnormality of T cell physiology (HP:0011840) | 2.04885304 |
| 128 | Viral hepatitis (HP:0006562) | 2.03057400 |
| 129 | Deep palmar crease (HP:0006191) | 2.02374174 |
| 130 | Hepatosplenomegaly (HP:0001433) | 2.02258174 |
| 131 | Chronic otitis media (HP:0000389) | 2.00853958 |
| 132 | Spinal canal stenosis (HP:0003416) | 1.99796874 |
| 133 | Generalized hypotonia (HP:0001290) | 1.99195420 |
| 134 | Iris hypopigmentation (HP:0007730) | 1.98082528 |
| 135 | Obstructive sleep apnea (HP:0002870) | 1.96678667 |
| 136 | Ankyloglossia (HP:0010296) | 1.96469394 |
| 137 | Abnormality of oral frenula (HP:0000190) | 1.96136478 |
| 138 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.95879213 |
| 139 | Episodic fever (HP:0001954) | 1.95732627 |
| 140 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.95677961 |
| 141 | Anxiety (HP:0000739) | 1.95072356 |
| 142 | Anorexia (HP:0002039) | 1.93805246 |
| 143 | Inappropriate behavior (HP:0000719) | 1.93444127 |
| 144 | Hypertensive crisis (HP:0100735) | 1.90168832 |
| 145 | Emphysema (HP:0002097) | 1.90032451 |
| 146 | Hypercortisolism (HP:0001578) | 1.87531709 |
| 147 | Glomerulopathy (HP:0100820) | 1.87388877 |
| 148 | Panhypogammaglobulinemia (HP:0003139) | 1.86236101 |
| 149 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.85942069 |
| 150 | Thoracic kyphosis (HP:0002942) | 1.85340649 |
| 151 | Neuronal loss in central nervous system (HP:0002529) | 1.85229191 |
| 152 | Nasal polyposis (HP:0100582) | 1.84220551 |
| 153 | Autoimmune thrombocytopenia (HP:0001973) | 1.81903573 |
| 154 | Acute lymphatic leukemia (HP:0006721) | 1.80981086 |
| 155 | Rapidly progressive (HP:0003678) | 1.79718746 |
| 156 | Skin rash (HP:0000988) | 1.78858319 |
| 157 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.78476509 |
| 158 | Upper motor neuron abnormality (HP:0002127) | 1.77649493 |
| 159 | Ocular albinism (HP:0001107) | 1.77262879 |
| 160 | Abnormality of the fingertips (HP:0001211) | 1.77088445 |
| 161 | Recurrent lower respiratory tract infections (HP:0002783) | 1.75929325 |
| 162 | Abnormality of the peritoneum (HP:0002585) | 1.75238838 |
| 163 | Abnormality of iron homeostasis (HP:0011031) | 1.74786115 |
| 164 | Basal cell carcinoma (HP:0002671) | 1.73177763 |
| 165 | Status epilepticus (HP:0002133) | 1.71242814 |
| 166 | Horizontal nystagmus (HP:0000666) | 1.67692642 |
| 167 | Fatigue (HP:0012378) | 1.65260600 |
| 168 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.63410462 |
| 169 | Focal dystonia (HP:0004373) | 1.63396998 |
| 170 | Neoplasm of the heart (HP:0100544) | 1.62920646 |
| 171 | Spastic gait (HP:0002064) | 1.61297752 |
| 172 | Limb dystonia (HP:0002451) | 1.60924497 |
| 173 | Ependymoma (HP:0002888) | 1.60356901 |
| 174 | Psychosis (HP:0000709) | 1.60311412 |
| 175 | Delusions (HP:0000746) | 1.59666846 |
| 176 | Polyphagia (HP:0002591) | 1.59546661 |
| 177 | Limb ataxia (HP:0002070) | 1.59302858 |
| 178 | Increased IgE level (HP:0003212) | 1.58887900 |
| 179 | Inability to walk (HP:0002540) | 1.58314105 |
| 180 | Elfin facies (HP:0004428) | 1.57928100 |
| 181 | Macroglossia (HP:0000158) | 1.57042001 |
| 182 | Recurrent fungal infections (HP:0002841) | 1.56032661 |
| 183 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.55847073 |
| 184 | Dementia (HP:0000726) | 1.55761070 |
| 185 | Overriding aorta (HP:0002623) | 1.55396059 |
| 186 | Lower limb asymmetry (HP:0100559) | 1.54764751 |
| 187 | Mediastinal lymphadenopathy (HP:0100721) | 1.54536295 |
| 188 | Torticollis (HP:0000473) | 1.53829537 |
| 189 | Increased cerebral lipofuscin (HP:0011813) | 1.53577243 |
| 190 | Drooling (HP:0002307) | 1.53233904 |
| 191 | Excessive salivation (HP:0003781) | 1.53233904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 4.14333679 |
| 2 | NTRK3 | 3.68475045 |
| 3 | EPHA4 | 3.23548999 |
| 4 | ERN1 | 3.18373201 |
| 5 | SIK2 | 2.58938733 |
| 6 | RIPK4 | 2.56923329 |
| 7 | MAP3K13 | 2.47405255 |
| 8 | MAP3K12 | 2.44553444 |
| 9 | MINK1 | 2.38365827 |
| 10 | IRAK4 | 2.36126782 |
| 11 | FES | 2.32980300 |
| 12 | MAP2K3 | 2.28779185 |
| 13 | KSR2 | 2.21671691 |
| 14 | CSK | 2.14151552 |
| 15 | DAPK1 | 2.10204401 |
| 16 | SMG1 | 2.07495759 |
| 17 | MAP3K4 | 2.00194408 |
| 18 | NTRK2 | 1.99982829 |
| 19 | MAP3K14 | 1.97987443 |
| 20 | CDK19 | 1.95051544 |
| 21 | CAMKK1 | 1.87452093 |
| 22 | EEF2K | 1.83335032 |
| 23 | DAPK2 | 1.80457150 |
| 24 | PAK6 | 1.77069115 |
| 25 | GRK6 | 1.77027314 |
| 26 | BTK | 1.69516792 |
| 27 | MAP4K1 | 1.61991691 |
| 28 | KSR1 | 1.60621667 |
| 29 | TAOK1 | 1.59021638 |
| 30 | MARK1 | 1.57980065 |
| 31 | MAP3K3 | 1.50648982 |
| 32 | TBK1 | 1.46905255 |
| 33 | PRKD3 | 1.45597563 |
| 34 | TYRO3 | 1.44863557 |
| 35 | EPHB1 | 1.44793690 |
| 36 | MAP2K7 | 1.43737554 |
| 37 | GRK5 | 1.43172810 |
| 38 | MAP2K4 | 1.42560201 |
| 39 | SIK1 | 1.42005369 |
| 40 | IKBKE | 1.37689301 |
| 41 | ALK | 1.37675365 |
| 42 | SCYL2 | 1.37294056 |
| 43 | IRAK3 | 1.35477726 |
| 44 | TXK | 1.34784386 |
| 45 | FGFR4 | 1.30564135 |
| 46 | TNK2 | 1.28341304 |
| 47 | MARK3 | 1.28216525 |
| 48 | CDK5 | 1.26717858 |
| 49 | RAF1 | 1.25478894 |
| 50 | CDK12 | 1.22103580 |
| 51 | ARAF | 1.21049706 |
| 52 | NTRK1 | 1.20742769 |
| 53 | JAK1 | 1.20218949 |
| 54 | STK10 | 1.16834926 |
| 55 | PKN2 | 1.16565408 |
| 56 | UHMK1 | 1.15919939 |
| 57 | LYN | 1.09952341 |
| 58 | PTK6 | 1.07920431 |
| 59 | ITK | 1.07510849 |
| 60 | CDC42BPA | 1.06698723 |
| 61 | PRPF4B | 1.05389256 |
| 62 | TNIK | 1.03395410 |
| 63 | CAMKK2 | 1.01286053 |
| 64 | MAP3K11 | 0.97843482 |
| 65 | SYK | 0.95889190 |
| 66 | TRIB3 | 0.94134463 |
| 67 | IKBKB | 0.93560344 |
| 68 | CDK18 | 0.91957113 |
| 69 | CDK15 | 0.90878139 |
| 70 | STK11 | 0.90379576 |
| 71 | CAMK1 | 0.88389084 |
| 72 | CDK11A | 0.87259457 |
| 73 | PRKCH | 0.85947243 |
| 74 | RET | 0.84479062 |
| 75 | STK38 | 0.84030505 |
| 76 | BRSK1 | 0.83724373 |
| 77 | CDK14 | 0.83123374 |
| 78 | NME2 | 0.81460816 |
| 79 | SIK3 | 0.80628404 |
| 80 | MAP3K10 | 0.79016937 |
| 81 | NEK1 | 0.78378223 |
| 82 | ZAP70 | 0.77615629 |
| 83 | PNCK | 0.76402391 |
| 84 | MAPK13 | 0.75556188 |
| 85 | MARK2 | 0.74693331 |
| 86 | MAP3K6 | 0.74683560 |
| 87 | CDK4 | 0.72862618 |
| 88 | FGFR3 | 0.72210597 |
| 89 | IRAK2 | 0.71451409 |
| 90 | PRKCG | 0.68666964 |
| 91 | MAPK12 | 0.67987228 |
| 92 | LRRK2 | 0.67929118 |
| 93 | TGFBR2 | 0.67459318 |
| 94 | HCK | 0.67025140 |
| 95 | CCNB1 | 0.65978188 |
| 96 | PDK1 | 0.65965442 |
| 97 | RIPK1 | 0.65828521 |
| 98 | YES1 | 0.65421806 |
| 99 | MAP3K8 | 0.62272097 |
| 100 | PLK2 | 0.61048682 |
| 101 | MOS | 0.59334498 |
| 102 | MAPK7 | 0.58675214 |
| 103 | RPS6KL1 | 0.58392485 |
| 104 | RPS6KC1 | 0.58392485 |
| 105 | MAP3K7 | 0.58064517 |
| 106 | TEC | 0.57673031 |
| 107 | BLK | 0.57117632 |
| 108 | MAP3K1 | 0.56495649 |
| 109 | KIT | 0.56247280 |
| 110 | CAMK4 | 0.54804267 |
| 111 | FGR | 0.53943574 |
| 112 | TTN | 0.52674891 |
| 113 | PIM1 | 0.52320880 |
| 114 | CSF1R | 0.51504699 |
| 115 | PRKCQ | 0.49632921 |
| 116 | MAPK11 | 0.49269188 |
| 117 | PRKG2 | 0.48530544 |
| 118 | NEK2 | 0.48402443 |
| 119 | HIPK2 | 0.48350742 |
| 120 | MATK | 0.47739113 |
| 121 | CDK6 | 0.47023418 |
| 122 | IRAK1 | 0.46768878 |
| 123 | DAPK3 | 0.45915813 |
| 124 | MAP2K2 | 0.45609536 |
| 125 | PRKD2 | 0.45247846 |
| 126 | FYN | 0.44146178 |
| 127 | RPS6KA6 | 0.43719576 |
| 128 | BMPR2 | 0.43475395 |
| 129 | LATS2 | 0.42973369 |
| 130 | RPS6KA2 | 0.42060410 |
| 131 | CLK1 | 0.41629199 |
| 132 | MAPKAPK2 | 0.40025800 |
| 133 | BMX | 0.39009017 |
| 134 | MAP2K6 | 0.38514045 |
| 135 | MAPK10 | 0.38413717 |
| 136 | TAOK3 | 0.37493503 |
| 137 | PAK4 | 0.37137167 |
| 138 | PTK2B | 0.36585866 |
| 139 | LCK | 0.36573663 |
| 140 | MAP3K2 | 0.35367462 |
| 141 | TESK2 | 0.34977882 |
| 142 | SGK3 | 0.34001750 |
| 143 | CDC7 | 0.33754678 |
| 144 | JAK3 | 0.31891394 |
| 145 | RPS6KA3 | 0.31125226 |
| 146 | SGK1 | 0.31097925 |
| 147 | ICK | 0.30960222 |
| 148 | TYK2 | 0.30942520 |
| 149 | PRKCZ | 0.30584473 |
| 150 | JAK2 | 0.30411903 |
| 151 | TAOK2 | 0.30293422 |
| 152 | PDPK1 | 0.29827578 |
| 153 | CAMK2A | 0.29778032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.67638211 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.62301488 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.43734164 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.40831143 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.35250916 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.33749327 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.28771713 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.25642158 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.24027539 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.14359170 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 2.00880260 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 1.97990756 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.95795132 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94528260 |
| 15 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.94080197 |
| 16 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.92590450 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.89673840 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.85532079 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.81321730 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.78387399 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.77213250 |
| 22 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.74048140 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.67846784 |
| 24 | Viral myocarditis_Homo sapiens_hsa05416 | 1.64213274 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62872370 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.61237522 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.57474869 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.54576944 |
| 29 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.54519728 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.52221631 |
| 31 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.49382705 |
| 32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.49066611 |
| 33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.46187287 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45972026 |
| 35 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.44923710 |
| 36 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.43212116 |
| 37 | Malaria_Homo sapiens_hsa05144 | 1.43111049 |
| 38 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.40347283 |
| 39 | Long-term depression_Homo sapiens_hsa04730 | 1.40058124 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34407981 |
| 41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.32900771 |
| 42 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32756119 |
| 43 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.31331860 |
| 44 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28881141 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.27559977 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 1.27206688 |
| 47 | Cocaine addiction_Homo sapiens_hsa05030 | 1.25591694 |
| 48 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24936830 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 1.19796599 |
| 50 | Glioma_Homo sapiens_hsa05214 | 1.19738662 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19221981 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.18256971 |
| 53 | Gap junction_Homo sapiens_hsa04540 | 1.17981892 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.17159505 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.16777946 |
| 56 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.16669282 |
| 57 | Insulin secretion_Homo sapiens_hsa04911 | 1.16465291 |
| 58 | Taste transduction_Homo sapiens_hsa04742 | 1.16310132 |
| 59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15993040 |
| 60 | Lysosome_Homo sapiens_hsa04142 | 1.14421827 |
| 61 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14072111 |
| 62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12267924 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 1.11727880 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 1.11115086 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 1.11090331 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.09847117 |
| 67 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.07844792 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 1.07125447 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.05778438 |
| 70 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.05710645 |
| 71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.04214537 |
| 72 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.03397768 |
| 73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.03221249 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.95680514 |
| 75 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.93878816 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.93815451 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.91862188 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91740989 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.89665703 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88961659 |
| 81 | Colorectal cancer_Homo sapiens_hsa05210 | 0.88508334 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.87657606 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87356677 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.87237894 |
| 85 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86470668 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.86364879 |
| 87 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.85715133 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85650987 |
| 89 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84387252 |
| 90 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84267332 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.83461688 |
| 92 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.82482984 |
| 93 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77387602 |
| 94 | Melanogenesis_Homo sapiens_hsa04916 | 0.77166474 |
| 95 | HTLV-I infection_Homo sapiens_hsa05166 | 0.76149261 |
| 96 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.75715148 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.74299187 |
| 98 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73672017 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.73649438 |
| 100 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.73011809 |
| 101 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72320762 |
| 102 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71925222 |
| 103 | Shigellosis_Homo sapiens_hsa05131 | 0.71598703 |
| 104 | Platelet activation_Homo sapiens_hsa04611 | 0.71427843 |
| 105 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.70473636 |
| 106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70186975 |
| 107 | Bladder cancer_Homo sapiens_hsa05219 | 0.69463763 |
| 108 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.69281515 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69100094 |
| 110 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66921161 |
| 111 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.66100011 |
| 112 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64547915 |
| 113 | Amoebiasis_Homo sapiens_hsa05146 | 0.63945665 |
| 114 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61464007 |
| 115 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60406939 |
| 116 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59950890 |
| 117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.59641669 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59524119 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58765411 |
| 120 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58040633 |
| 121 | Phototransduction_Homo sapiens_hsa04744 | 0.57327526 |
| 122 | Salmonella infection_Homo sapiens_hsa05132 | 0.57151349 |
| 123 | Tuberculosis_Homo sapiens_hsa05152 | 0.57062633 |
| 124 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57013899 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55687787 |
| 126 | Alcoholism_Homo sapiens_hsa05034 | 0.54522891 |
| 127 | Axon guidance_Homo sapiens_hsa04360 | 0.54346601 |
| 128 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54124339 |
| 129 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53791645 |
| 130 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53048458 |
| 131 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52647082 |
| 132 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51978758 |
| 133 | Thyroid cancer_Homo sapiens_hsa05216 | 0.51691589 |
| 134 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51407530 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50667588 |
| 136 | Hepatitis B_Homo sapiens_hsa05161 | 0.48931066 |
| 137 | Insulin resistance_Homo sapiens_hsa04931 | 0.48418901 |
| 138 | Prion diseases_Homo sapiens_hsa05020 | 0.48340441 |
| 139 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46911078 |
| 140 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46880587 |
| 141 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46754678 |
| 142 | Prostate cancer_Homo sapiens_hsa05215 | 0.46658059 |
| 143 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46080600 |
| 144 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.44782267 |
| 145 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44534885 |
| 146 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44523816 |
| 147 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.43880596 |
| 148 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43371599 |
| 149 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43195792 |
| 150 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43069353 |
| 151 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42489116 |
| 152 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40375814 |
| 153 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.39966657 |

